Header cover image

U.S. Pharma Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies321
  • 7D-0.5%
  • 3M-1.4%
  • 1Y17.7%
  • YTD11.5%

Over the last 7 days, the Pharma industry has remained flat, although notably Pfizer gained 6.3%. The past year has been better, since the industry has gained 18% in that time.

Industry Valuation and Performance

Has the U.S. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021US$1.6tUS$361.1bUS$38.1b23.4x
Tue, 26 Oct 2021US$1.5tUS$340.0bUS$24.9b20.6x
Thu, 23 Sep 2021US$1.5tUS$337.6bUS$25.9b22x
Sat, 21 Aug 2021US$1.6tUS$338.5bUS$25.8b18.9x
Sat, 05 Jun 2021US$1.5tUS$323.4bUS$21.4b20.5x
Tue, 09 Mar 2021US$1.4tUS$304.8bUS$15.6b24x
Mon, 30 Nov 2020US$1.3tUS$284.8bUS$25.5b20.6x
Thu, 03 Sep 2020US$1.3tUS$279.3bUS$31.3b24.9x
Sun, 07 Jun 2020US$1.3tUS$282.6bUS$35.8b19.1x
Sat, 29 Feb 2020US$1.2tUS$279.5bUS$37.4b18.4x
Tue, 03 Dec 2019US$1.2tUS$295.1bUS$38.6b17.7x
Fri, 06 Sep 2019US$1.1tUS$293.5bUS$38.0b14.9x
Mon, 10 Jun 2019US$1.1tUS$293.1bUS$32.9b15.5x
Sun, 03 Mar 2019US$1.2tUS$279.0bUS$22.7b19.1x
Wed, 05 Dec 2018US$1.3tUS$292.6bUS$17.6b13x
PE Ratio

13x

Total Market Cap: US$1.3tTotal Earnings: US$17.6bTotal Revenue: US$292.6b0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 19.4x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 29% per year over the last three years, and revenues for these companies have grown 7.3% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Pharma industry?

Pharma-0.53%

Industry PE: Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 19.4x. However analysts expect its future annual earnings growth (12%) to be largely in line with prior year's earnings growth, so the market might believe analysts are underestimating its future growth since investors are willing to pay a bigger premium today.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 12% over the next 5 years. This is roughly in line with its past earnings growth rate.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
PFE Pfizer6.3%+US$18.0b45.0%PE15.5x
CTLT Catalent4.1%+US$890.2m35.8%PE41.6x
ITCI Intra-Cellular Therapies5.4%+US$176.8m69.9%PS49x
RPRX Royalty Pharma0.8%+US$141.7m0.7%PE32.5x
SAVA Cassava Sciences5.2%+US$110.8m621.1%PB8.4x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MRK

US$79.16

Merck

7D

-1.9%

1Y

-0.9%

PRGO

US$37.78

Perrigo

7D

-8.2%

1Y

-21.3%

PFE

US$54.00

Pfizer

7D

6.3%

1Y

45.0%

ZTS

US$219.32

Zoetis

7D

-3.1%

1Y

35.8%